Prominent provider of mental health treatment, Clinical Partners Limited, has successfully acquired Oxford ADHD & Autism Centre (“Oxford ADHD”), strengthening its portfolio of neurodevelopmental services.
As one of the UK’s largest independent providers of mental health and neurodevelopmental services, Clinical Partners caters to both the NHS and private sectors. With a workforce of over 400 professionals across the country, the company annually supports approximately 40,000 patients. With their rapid growth, this acquisition signifies Clinical Partners’ dedication to expanding their capacity and reaching a wider population.
Established in 2015 by Dr Polly Branney, Oxford ADHD & Autism Centre specialises in diagnosing and supporting individuals, both children and adults, with neurodevelopmental disorders and related conditions. With a team of around 40 specialists, they bring their expertise and experience to join Clinical Partners.
Dr Alice Parshall, Chief Medical Officer of Clinical Partners, expressed her enthusiasm, stating, “We warmly welcome the team from Oxford ADHD Centre to Clinical Partners. Polly and her team have built a reputation as a trusted and high-quality provider in the Oxford area, and we share a commitment to delivering safe and effective services. We look forward to collaborating and leveraging our combined knowledge and expertise to further enhance our services for patients and their families.”
Dr Polly Branney remarked, “Eight years ago, I founded the clinic due to the evident lack of local provision for the increasing number of autism and ADHD referrals. Since then, we have provided treatment for over 3,000 patients and collaborated with numerous NHS services to ensure that both adults and children have access to expert support.
“As a small independent clinic facing growing demand, it became clear that we could have a more significant impact as part of a larger group organisation that would invest in growth and training. Clinical Partners is the ideal fit for us, and I wish everyone success in the next chapter of Oxford ADHD’s mission.”
On June 20, 2023, Clinical Partners completed the acquisition of the entire share capital of Oxford ADHD for an undisclosed amount. CapEQ (M&A) provided advisory services to Oxford ADHD, with legal counsel from Freeths. Keystone Law provided legal advice to Clinical Partners.
Mark Sapsford, Director at CapEQ, added, “Access to mental health support is crucial in today’s world, and we are proud to have facilitated this transaction. We extend our best wishes to both parties as they combine their businesses to provide even more effective support and treatment in the Thames Valley and beyond.”
Freeths partner Malin Svanberg Larsson commented, “We are delighted to have assisted Polly and the Oxford ADHD team in completing this transaction. We wish both parties every success as they continue to deliver invaluable mental health support to patients across the NHS and the private sector.”
